86 -10 (84) 2025 - Oripova F.Sh., Tolibova A.E. - COMPREHENSIVE ASSESSMENT OF RISK FACTORS FOR RECURRENCE OF ENDOMETRIOID CYSTS AND THEIR FERTILITY-PRESERVING TREATMENT

COMPREHENSIVE ASSESSMENT OF RISK FACTORS FOR RECURRENCE OF ENDOMETRIOID CYSTS AND THEIR FERTILITY-PRESERVING TREATMENT

Oripova F.Sh. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Tolibova A.E. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Endometriotic ovarian cysts are the most commonly diagnosed manifestation of endometriosis, with a recurrence rate ranging from 12% to 30% within 2–5 years after adequate removal. Their comprehensive assessment can help predict the course of the disease and improve the effectiveness of its prevention. This study presents an analysis of the literature and a review of modern approaches to the treatment of endometriotic ovarian cysts, focusing on the preservation and restoration of fertility. Special attention is given to the effectiveness of assisted reproductive technologies in patients after treatment of endometriomas using various methods.

Keywords: endometriotic cyst, recurrence, risk factors, ovarian reserve, infertility, in vitro fertilization, prevention.

First page

499

Last page

505

For citation:Oripova F.Sh., Tolibova A.E. - COMPREHENSIVE ASSESSMENT OF RISK FACTORS FOR RECURRENCE OF ENDOMETRIOID CYSTS AND THEIR FERTILITY-PRESERVING TREATMENT//New Day in Medicine 10(84)2025 499-505 https://newdayworldmedicine.com/en/new_day_medicine/10-84-2025

List of References

1. Becker CM, Gattrell WT, Gude K, Singh SS. Reevaluating response and failure of medical treatment of endometriosis: a systematic review. Fertil Steril. 2017; 108(1): 125-136. DOI: 10.1016/j.fertnstert.2017.05.004
2. Becker CM, Gattrell WT, Gude K, Singh SS. Reevaluating response and failure of medical treatment of endometriosis: a systematic review. Fertil Steril. 2017; 108(1): 125-136. DOI: 10.1016/j.fertnstert.2017.05.004.
3. Casper RF. Introduction: a focus on the medical management of endometriosis. Fertil Steril. 2017; 107: 521-522. DOI: 10.1016/j.fertnstert.2017.01.008.
4. Dunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, d’Hooghe T, de Bie B. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014; 29: 400-412. DOI: 10.1093/humrep/det457.
5. Ferrero S, Scala C, Racca A, Calanni L, Remorgida V, Venturini PL, Maggiore LRU. Second surgery for recurrent unilateral endometriomas and impact on ovarian reserve: A case-control study. Fertil Steril. 2015; 103: 1236-1243. DOI: 10.1016/j. fertnstert.2015.01.032.
6. Goodman LR, Goldberg JM, Flyckt RL, Gupta M, Harwalker J, Falcone T. Effect of surgery on ovarian reserve in women with endometriomas, endometriosis and controls. Am J Obstet Gynecol. 2016; 215(5): 589. DOI: 10.1016/j.ajog.2016.05.029.
7. Ikhtiyarova, G. A., MZh, A., ZSh, K., & Kalimatova, D. M. (2021). Prospects for the diagnosis of endometriosis taking into account the role of genetic factors in the pathogenesis of breast cancer. Mother and child, 1, 12-16.
8. Jayaprakasan K, Becker C, Mittal M. The effect of surgery for endometriomas on fertility: Scientific impact paper No. 55
9. Jee B.C., Lee J.Y., Suh C.S. et al. Impact of GnRH agonist treatment on recurrence of ovarian endometriosis after conservative laparoscopic surgery Fertil Steril. 2009. № 91 (1). Р. 40-44.
10. Jiang D, Nie X. Effect of endometrioma and its surgical excision on fertility (Review). Exp Ther Med. 2020; 20(5): 114. DOI: 10.3892/etm.2020.9242.

    file

    download